Wealthspire Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1646247 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$220,118

+$215,876 QoQ

Shares Held

6,497

+2993.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#487

of 671 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wealthspire Advisors, LLC holds $2,181,659 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	30,583	$752,647
2	ZTS	Zoetis Inc.	7,817	$561,729
3	TRLV	Trulieve Cannabis Corp.	23,200	$228,056
4	TEVA	Teva Pharmaceutical Industries Ltd This page	6,497	$220,118
5	AKBA	Akebia Therapeutics, Inc.	180,002	$205,202
6	HLN	Haleon plc	10,230	$95,445
7	RMTI	Rockwell Medical, Inc.	15,184	$83,510
8	OGI	Organigram Global Inc.	18,522	$18,892

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,118	6,497	+2993.8%	Shares	Sole	2026-08-11
2025-09-30	$4,242	210	-99.9%	Shares	Sole	2025-11-14
2023-06-30	$1,055,126	140,123	-6.7%	Shares	Sole	2023-08-01
2023-03-31	$1,328,588	150,123	-1.5%	Shares	Sole	2023-05-09
2022-12-31	$1,390,562	152,474	-30.7%	Shares	Sole	2023-02-14
2022-09-30	$1,776,392	220,123	+46.6%	Shares	Sole	2022-11-14
2022-06-30	$1,128,924	150,123	-53.1%	Shares	Sole	2022-08-09
2022-03-31	$3,005,954	320,123	+12.4%	Shares	Sole	2022-05-09
2021-12-31	$2,281,808	284,870	+100.1%	Shares	Sole	2022-02-14
2021-09-30	$1,386,498	142,351	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.